2024 annual financial data
Design Therapeutics 2024 Net income growth
Direct answer
Net income growth was 25.84%.
Operating income was -62,383,000 USD and net income was -49,588,000 USD.
Operating cash flow was -43,105,000 USD.
Get free Design Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -62,383,000 USD
- Net income
- -49,588,000 USD
- Operating cash flow
- -43,105,000 USD